PreView: The Preventive Video Education in Waiting Rooms Program

This clinical trial studies how well PreView, preventive video education, works in increasing rates of breast, cervical and colorectal cancer screening, improving participants' stage of change with respect to age appropriate cancer screening and increasing patient-provider discussions about prostate cancer screening.

Study Overview

• Status: Completed
• Conditions: Health Status Unknown
• Intervention / Treatment: Other: Questionnaire Administration; Other: Computer-Assisted Intervention; Other: Computer-Assisted Intervention

Detailed Description

PRIMARY OBJECTIVES:

I. To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, pap tests, colon cancer tests or prostate specific antigen (PSA) testing discussions with primary care physicians compared with participants who receive usual care.

II. To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or colorectal cancer (CRC) compared with usual care.

III. To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.

OUTLINE: Patients are randomized into 1 of 2 groups.

GROUP I: Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.

GROUP II: Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.

• Study Type: Interventional
• Enrollment (Actual): 508
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Concord, California, United States, 94520
      • John Muir Medical Center-Concord Campus
    • San Francisco, California, United States, 94115
      • UCSF Medical Center-Mount Zion

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Without a history of cancer

Exclusion Criteria:

• With a history of cancer (for whom subsequent procedures would be surveillance and not screening)
• Individuals who do not speak English or Spanish (except for the testimonials)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Group I (PreView); Patients complete PreView, the Video Doctor plus Provider Alert, over 45 minutes on an iPad in the waiting room before a doctor visit.	Other: Questionnaire Administration; Ancillary studies; Other: Computer-Assisted Intervention; Complete PreView; Other: Computer-Assisted Intervention; Watch an educational video
Active Comparator: Group II (educational video); Patients watch a video about healthy lifestyles including information about exercise and healthy eating over 45 minutes on an iPad in the waiting room before a doctor visit.	Other: Questionnaire Administration; Ancillary studies; Other: Computer-Assisted Intervention; Complete PreView; Other: Computer-Assisted Intervention; Watch an educational video

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changing participants' readiness to be screened for breast, cervical and colorectal cancer	To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, Pap tests, colon cancer tests or PSA testing discussions with primary care physicians compared with participants who receive usual care	Up to 3 hours from pre-visit to post-visit interview.
Increasing physician-patient discussions about PSA screening measured by chart review	To determine the extent that PreView increases participants' readiness to be screened for breast cancer, cervical cancer or CRC compared with usual care.	Baseline up to 14 months
Increasing rates of breast, cervical and colorectal cancer screening	To determine the extent that PreView increases the likelihood that PSA testing will be discussed in primary care physician visits compared with usual care.	From Baseline up to 14 months

Collaborators and Investigators

• Sponsor: University of California, San Francisco
• Collaborators: National Cancer Institute (NCI)
• Investigators: Principal Investigator: Judith Walsh, UCSF Medical Center-Mount Zion

Publications and helpful links

General Publications

• Walsh J, Potter M, Salazar R, Ozer E, Gildengorin G, Dass N, Green L. PreView: a Randomized Trial of a Multi-site Intervention in Diverse Primary Care to Increase Rates of Age-Appropriate Cancer Screening. J Gen Intern Med. 2020 Feb;35(2):449-456. doi: 10.1007/s11606-019-05438-0. Epub 2019 Nov 14.

Study record dates

Study Major Dates

• Study Start: July 1, 2013
• Primary Completion (Actual): February 1, 2019
• Study Completion (Actual): March 1, 2019

Study Registration Dates

• First Submitted: October 6, 2014
• First Submitted That Met QC Criteria: October 9, 2014
• First Posted (Estimate): October 15, 2014

Study Record Updates

• Last Update Posted (Actual): July 22, 2020
• Last Update Submitted That Met QC Criteria: July 20, 2020
• Last Verified: July 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: 14988 (Other Identifier: UCSF Medical Center-Mount Zion); NCI-2017-00456 (Registry Identifier: CTRP (Clinical Trial Reporting Program)); R01CA158027 (U.S. NIH Grant/Contract)